Señal de la máquina
Grupo activo de compras — 5 iniciados distintos, $1.5M, la ventana termina el Aug 20, 2026.
Cifras calculadas a partir de notificaciones regulatorias oficiales — .
Analistasobjetivo 30.85 USD (+37%) · consenso 4.5/5 · 14 compra · 2 mantener · 0 venta
Propiedadiniciados 1.21% · instituciones 115.53% · posiciones cortas 11.9% del flotante
En USD · a Oct 19, 2026
Pregúntale a la máquina
Busca y compara operaciones de iniciados, sociedades y sus estadísticas en lenguaje natural. Tu pregunta se convierte en una consulta sobre los datos disponibles, no en una conversación ni en asesoramiento de inversión.
Solo datos de Elanco Animal Health Inc. Sin búsqueda web. Se excluyen las estadísticas globales de cada iniciado.
Una búsqueda ejecutada consume un crédito, incluso sin resultados. Los errores y las preguntas no compatibles no consumen créditos.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.
Fuente de información de mercado · Oct 19, 2026
Identidad según la SEC · Oct 19, 2026
Cronología en el mercado · historial completo
84 compras2 ventas— precio de cierrebarra = volumen usd, escala √haz clic en un periodo para filtrar la tabla
| Iniciado | Tipo | Valor · USD | Señales | Detalle |
|---|---|---|---|---|
| Simmons Jeffrey Nhistorial | AsignaciónD (derivado) | $2.8K | SEC |
| VanHimbergen Robert Mhistorial | AsignaciónD (derivado) | $197 | SEC |
| Modi Rajeev A. | AsignaciónD (derivado) | $1.5K | SEC |
| Bettington Timothy J | Venta | $100.1K | SEC |
| Modi Rajeev A. | AsignaciónD (derivado) | $1.5K | SEC |
| Simmons Jeffrey Nhistorial | AsignaciónD (derivado) | $2.8K | SEC |
| VanHimbergen Robert Mhistorial | AsignaciónD (derivado) | $197 | SEC |
| Anand Kapila Khistorial | AsignaciónD (derivado) | $14.4K | SEC |
| Modi Rajeev A. | AsignaciónD (derivado) | $1.5K | SEC |
| VanHimbergen Robert Mhistorial | AsignaciónD (derivado) | $197 | SEC |
| Simmons Jeffrey Nhistorial | AsignaciónD (derivado) | $2.8K | SEC |
| Simmons Jeffrey Nhistorial | AsignaciónD (derivado) | $2.8K | SEC |
| VanHimbergen Robert Mhistorial | AsignaciónD (derivado) | $197 | SEC |
| Modi Rajeev A. | AsignaciónD (derivado) | $1.5K | SEC |
| VanHimbergen Robert Mhistorial | AsignaciónD (derivado) | $197 | SEC |
| Simmons Jeffrey Nhistorial | AsignaciónD (derivado) | $2.8K | SEC |
| Modi Rajeev A. | AsignaciónD (derivado) | $1.5K | SEC |
| Kurzius Lawrence Erikhistorial | Compra | $935.9K | conv 60AgrupadaTamaño inusual | SEC |
| O'Neill Shiv | Compra | $94.3K | conv 58AgrupadaPrimera en 12 meses | SEC |
| Harrington Michael Jhistorial | Compra | $109.1K | conv 51AgrupadaPrimera en 12 meses | SEC |
| VanHimbergen Robert Mhistorial | AsignaciónD (derivado) | $197 | SEC |
| VanHimbergen Robert Mhistorial | Compra | $96.9K | conv 41Agrupada | SEC |
| Herendeen Paulhistorial | Compra | $236.9K | conv 45AgrupadaPrimera en 12 meses | SEC |
| Modi Rajeev A. | AsignaciónD (derivado) | $1.5K | SEC |
| Simmons Jeffrey Nhistorial | AsignaciónD (derivado) | $2.8K | SEC |